The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 23, 2016

Filed:

Jul. 16, 2008
Applicants:

Sung Youb Jung, Suwon-si, KR;

Chang Ki Lim, Suwon-si, KR;

Dae Hae Song, Seoul, KR;

Sung Min Bae, Seongnam-si, KR;

Young Hoon Kim, Seoul, KR;

SE Chang Kwon, Seoul, KR;

Gwan Sun Lee, Seoul, KR;

Inventors:

Sung Youb Jung, Suwon-si, KR;

Chang Ki Lim, Suwon-si, KR;

Dae Hae Song, Seoul, KR;

Sung Min Bae, Seongnam-si, KR;

Young Hoon Kim, Seoul, KR;

Se Chang Kwon, Seoul, KR;

Gwan Sun Lee, Seoul, KR;

Assignee:

HANMI SCIENCE CO., LTD, Hwaseong-si, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/605 (2006.01); A61K 38/26 (2006.01); C07K 14/46 (2006.01); C07K 14/575 (2006.01);
U.S. Cl.
CPC ...
C07K 14/46 (2013.01); A61K 38/26 (2013.01); C07K 14/57563 (2013.01); C07K 14/605 (2013.01);
Abstract

The present invention relates to an N-terminal amino acid-modified insulinotropic peptide having a high activity, and to a pharmaceutical composition comprising the same. The insulinotropic peptide derivatives according to the present invention exhibit therapeutic effects, which are not observed in native and other insulinotropic peptide analogs. Therefore, the insulinotropic peptide derivatives and the pharmaceutical composition comprising the same according to the present invention can be effectively provided for the treatment of the diseases.


Find Patent Forward Citations

Loading…